← Open Payments lookup

JASON HASS: Open Payments

NPI 1831176486 · SUPERIOR, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$389 in 22 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $702 · 2025 $389

Food & beverage: $389
CompanyPaymentsAmount
Novo Nordisk Inc4$61
Otsuka America Pharmaceutical, Inc.3$50
Gilead Sciences, Inc.3$49
Abbott Laboratories2$44
ABBVIE INC.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
AstraZeneca Pharmaceuticals LP1$35
Amgen Inc.2$29
Exact Sciences Corporation1$17
Lundbeck LLC1$15

Products named: REXULTI, Ozempic, FREESTYLE LIBRE 3, CAPLYTA, IMFINZI, EVENITY, VRAYLAR, Cologuard Collection Kit.

Industry payments across NE — which companies pay providers there.